Abiopharma

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: I-MAB - American Depositary Shares.

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: I-MAB - American Depositary Shares.

NASDAQ traded attribute type Security_Name was changed. Previous value: I-MAB - American Depositary Shares. New value: I-MAB - American Depositary Shares.

NASDAQ traded attribute type Security_Name was changed. Previous value: NLS Pharmaceutics Ltd. - Common Shares. New value: NLS Pharmaceutics Ltd. - Ordinary Shares.

Envista Reports Third Quarter 2025 Results

Rubicon Organics to Report Q3 2025 Results

BAX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Ascentage Pharma to Participate in Two Upcoming Investor Conferences in November 2025

Dynamix Corporation III Announces Pricing of $175 Million Initial Public Offering

Director Jashnani Yogesh 🟢 acquired 112.2K shares (1 derivative) of Airsculpt Technologies, Inc. (AIRS) Transaction Date: Oct 27, 2025 | Filing ID: 103868

New Form SCHEDULE 13G - RAPT Therapeutics, Inc. Filed: 2025-10-29 AccNo: 0001193125-25-256980 Size: 12 KB

National Healthcare Properties Announces Release Date for Third Quarter 2025 Results

More strong drilling results outside current resource point to further growth

De nouveaux résultats de forage solides à l’extérieur des ressources actuelles pointent vers une croissance supplémentaire

EVNIN LUKE 🔴 sold 177.1K shares of Werewolf Therapeutics, Inc. (HOWL) at $1.72 Transaction Date: Oct 27, 2025 | Filing ID: 000375